Keros Therapeutics Inc (KROS)

EBITDA Margin

0.00%

Quarterly · Period ending:

KROS logo

KROS EBITDA Margin

Latest reported0.00%
KROS Quarterly EBITDA Margin (-105.32% → 0.00%)
High-resolution chart · PNG

KROS ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Keros Therapeutics Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
0%
-6,350.1362%
-6,383.1169%
-58.2597%
-179.1502%
75.191%
-957.9882%
-13,567.5258%
-121,489.1892%
-51,610.8434%
-27,969.2308%
-490,375%
0%
0%
0%
0%
0%
0%
-24.185%
0%
-15,530%
0%
0%
0%
0%
0%
-14.72%
-139.64%
-88.96%
-105.32%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.